Enhancement of hybrid-fiber types in rat soleus muscle after clenbuterol administration during hindlimb unloading

Canadian Journal of Physiology and Pharmacology

Volumn 82, Issue 5, 2004, Pages 311-318

  Picquet, F ^a   De Doncker, L ^a   Falempin, M ^a  

^a UPRES EA 1032   (France)

Author keywords

2 agonist; Clenbuterol; Contractile parameters; Countermeasure; Immunohistochemistry; Myosin; Simulated microgravity; Soleus

Indexed keywords

CLENBUTEROL; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; FAST MUSCLE FIBER; HINDLIMB; MALE; MOLECULAR EVOLUTION; MORPHOLOGY; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE FORCE; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; RAT; SLOW MUSCLE FIBER; SOLEUS MUSCLE; TISSUE TYPES;

ANIMALS; CLENBUTEROL; HINDLIMB SUSPENSION; MALE; MUSCLE CONTRACTION; MUSCLE FIBERS; MUSCLE, SKELETAL; RATS; RATS, WISTAR;

EID: 4143105855     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y04-034     Document Type: Article

References (43)

1. Babij, P., and Booth, F.W. 1988. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle. Am. J. Physiol. Cell Physiol. 254: C657-C660.
2. Bonaventure, L.A., Thissen, J.P., and Lebacq, J. 2002. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am. J. Physiol. Endocrinol. Metab. 282: E31-E37.
3. Carter, W.J., Dang, A.Q., Faas, F.H., and Lynch, M.E. 1991. Effects of clenbuterol on skeletal muscle mass, body composition and recovery from surgical stress in senescent rats. Metabolism, 40: 855-860.
4. Chen, K.D., and Alway, S.E. 2001. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats. Muscle Nerve 24: 211-222.
5. Desaphy, J.F., Pierno, S., De Luca, A., Didonna, P., and Camerino, D.C. 2003. Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders. Mol. Pharmacol. 63: 659-670.
6. Duncan, N.D., Williams, D.A., and Lynch, G.S. 2000. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats. Clin. Sci. (Lond). 98: 339-347.
7. Dupont-Versteegden, E.E., Katz, M.S., and Mc Carter, R.J. 1995. Beneficial versus adverse effects of long-term use of clenbuterol in mdx mice. Muscle Nerve 18: 1447-1459.
8. Edgerton, V.R., and Roy, R.R. 1996. Neuromuscular adaptations to actual and simulated spaceflight. In Environmental Physiology: Handbook of Physiology, Vol. 1. Edited by M.J. Fregly and C.M. Blatteis. American Physiology Society, Bethesda. pp. 721-763.
9. Falempin, M., and Fodili In-Albon, S. 1999. Influence of brief daily tendon vibration on rat soleus muscle in non-weight-bearing situation. J. Appl. Physiol. 87: 3-9.
10. Falempin, M., Leclercq, T., Leterme, D., and Mounier, Y. 1990. Time-course of soleus muscle-change in and recovery from disuse atrophy. Physiologist, 33: S88-S89.
11. Falempin, M., Fodili, S., Leterme, D., and Mounier, Y. 1997. Functional effects of uridine triphosphate on the atrophied soleus muscle of rat after unloading. Muscle Nerve 20: 172-178.
12. Fraysse, B., Guillet, C., Huchet-Cadiou, C., Camerino, D.C., Gascan, H., and Leoty, C. 2000. Ciliary neurotrophic factor prevents unweighting-induced functional changes in rat soleus muscle. J. Appl. Physiol. 88: 1623-1630.
13. Fitts, R.H., Metzger, J.M., Riley, D.A., and Unsworth, B.R. 1986. Models of disuse: a comparison of hindlimb suspension and immobilization. J. Appl. Physiol. 60: 1946-1953.
14. Guth, L., and Samaha, F.J. 1969. Qualitative differences between actomyosin ATPase of slow and fast mammalian muscles. Exp. Neurol. 25: 138-152.
15. Kim, Y.S., and Sainz, R.D. 1992. β-adrenergic agonists and hypertrophy of skeletal muscles. Life Sci. 50: 397-407.
16. Kirby, C.R., Ryan, M.J., and Booth, F.W. 1992. Eccentric exercise training as a countermeasure to non-weight-bearing soleus muscle atrophy. J. Appl. Physiol. 73: 1894-1899.
17. Loukianov, E., Ji, Y., Grupp, I.L., Kirkpatrick, D.L., Baker, D.L., Loukianova, T., Grupp, G., Lytton, J., Walsh, R.A., and Periasamy, M. 1998. Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. Circ. Res. 83: 889-897.
18. Maltin, C.A., Hay, S.M., Delday, M.I., Smith, F.G., Lobley, G.E., and Reeds, P.J. 1987. Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms. Biosci. Rep. 7: 525-532.
19. Maltin, C.A., Hay, S.M., Delday, M.I., Smith, F.G., Lobley, G.E., and Reeds, P.J. 1989. The action of the β-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles. Biochem. J. 261: 965-971.
20. McDonald, K.S., and Fitts, R.H. 1995. Effect of hindlimb unloading on rat soleus fiber force, stiffness, and calcium sensitivity. J. Appl. Physiol. 79: 1796-1802.
21. Morey, E.R. 1979. Space flight and bone turnover: correlation with a new model of weightlessness. Bioscience, 29: 168-172.
22. Musacchia, X.J., Steffen, J.M., Fell, R.D., and Dombrowski, M.J. 1988. Comparative morphometry of fibers and capillaries in soleus following weightlessness (SL-3) and suspension. Physiologist, 31: S28-S29.
23. Ohira, Y. 2000. Neuromuscular adaptation to microgravity environment. Jpn. J. Physiol. 50: 303-314.
24. Oishi, Y., Imoto, K., Ogata, T., Taniguchi, K., Matsumoto, H., and Roy, R.R. 2002. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres. Acta Physiol. Scand. 176: 311-318.
25. Pette, D., and Staron, R.S. 1997. Mammalian skeletal muscle fiber type transitions. Int. Rev. Cytol. 170: 143-223.
26. Picquet, F., Stevens, L., Butler-Browne, G.S., and Mounier, Y. 1998. Differential effects of a six-day immobilization on newborn rat soleus muscles at two developmental stages. J. Muscle Res. Cell Motil. 19: 743-755.
27. 2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am. J. Physiol. Cell Physiol. 278: C582-C588.
28. Roy, R.R., Baldwin, K.M., and Edgerton, V.R. 1991. The plasticity of skeletal muscle: effects of neuromuscular activity. In Exercise and Sports Sciences Reviews, Vol. 19. Edited by J. Holloszy. Williams and Wilkins, Baltimore. pp. 269-312.
29. Sant'ana, Pereira, J.A., De Haan, A., Wessels, A., Moorman, A.F., and Sargeant, A.J. 1995. The mATPase histochemical profile of rat type IIX fibres: correlation with myosin heavy chain immunolabelling. Histochem. J. 27: 715-722.
30. Schiaffino, S., Gorza, L., Sartore, S., Saggin, L., Ausoni, S., Vianello, M., Gundersen, K., and Lomo, T. 1989. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J. Muscle Res. Cell Motil. 10: 197-205.
31. Sneddon, A.A., Delday, M.I., and Maltin, C.A. 2000. Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-α activity. Am. J. Physiol. Endocrinol. Metab. 279: E188-E195.
32. Stevens, L., Gohlsch, B., Mounier, Y., and Pette, D. 1999. Changes in myosin heavy chain mRNA and protein isoforms in single fibers of unloaded rat soleus muscle. FEBS Lett. 463: 15-18.
33. Stevens, L., Firinga, C., Gohlsch, B., Bastide, B., Mounier, Y., and Pette, D. 2000a. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am. J. Physiol. Cell Physiol. 279: C1558-C1563.
34. Stevens, L., Gohlsch, B., Mounier, Y., and Pette, D. 2000b. Upregulation of myosin heavy MHC Iα in rat muscles after unweighting and clenbuterol treatment. Bioch. Biophys. Res. Comm. 275: 418-421.
35. Stevens, L., Bastide, B., Kischel, P., Pette, D., and Mounier, Y. 2002. Time-dependent changes in expression of troponin subunit isoforms in unloaded rat soleus muscle. Am. J. Physiol. Cell Physiol. 282: C1025-C1030.
36. Stump, C.S., Overton, J.M., and Tipton, C.M. 1990. Influence of single hindlimb support during simulated weightlessness in the rat. J. Appl. Physiol. 68: 627-634.
37. Thomason, D.B., and Booth, J.W. 1990. Atrophy of the soleus muscle by hindlimb unweighting. J. Appl. Physiol. 68: 1-12.
38. Thomason, D.B., Herrick, R.E., and Baldwin, K.M. 1987a. Activity influences on soleus muscle myosin during rodent hindlimb suspension. J. Appl. Physiol. 63: 138-144.
39. Thomason, D.B., Herrick, R.E., Surdyka, D., and Baldwin, K.M. 1987b. Time course of soleus muscle myosin expression during hindlimb suspension and recovery. J. Appl. Physiol. 63: 130-137.
40. Von Deutsch, D.A., Abukhalaf, I.K., Wineski, L.E., Roper, R.R., Aboul-Enein, H.Y., Paulsen, D.F., and Potter, D.E. 2002. Distribution and muscle-sparing effects of clenbuterol in hindlimb-suspended rats. Pharmacology, 65: 38-48.
41. Winiarski, A.M., Roy, R.R., Alford, E.K., Chiang, P.C., and Edgerton, V.R. 1987. Mechanical properties of rat skeletal muscle after hindlimb suspension. Exp. Neurol. 96: 650-660.
42. Yang, Y.T., and Mc Elligott, M.A. 1989. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochemistry, 261: 1-10.
43. 2 agonist, retards atrophy in denervated muscles. Am. J. Physiol. Endocrinol. Metab. 252: E152-E155.